Login

Antony Mattessich, President & CEO, Ocular Therapeutix 00:00:00

Share On Facebook Share On Twitter

Ocular Therapeutix

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
From Washing Taxis to Top of the Legal World: A CEO's Journey and Transformation | Ray C. Espinosa, CEO, Manila Electric Co.
00:10:00
Asher Bio's Ivana Djuretic in a Fireside Chat | CRAIG GIBBS, PHD, MBA, CHIEF EXECUTIVE OFFICER, ASHER BIOTHERAPEUTICS, INC
00:10:00
Reflections on Education Leadership: Joel Klein's Journey|Joel Klein
00:10:00
A Soldier's Commitment to Family and Country|Col. Patrick Biggs
00:10:00
investors including Mary Meeker, Bond supports visionary founders throughout their life cycle of innovation and growth|Mood Rowghani,General Partner,Bond
00:10:00
Crypto currencies is Beyond Innovation|Michael Wu,Founder and CEO,Amber Group
00:10:00
CICT’s Forward-Thinking Strategies for Resilient Growth and Sustainable Operations|Tony Tan Tee Hieong,CEO,CapitaLand Integrated Commercial Trust
00:00:00
Compumedics expects to be back in profit for FY23 - David Lawson, CFO, Compumedics Ltd
00:10:00
Dry Bulk Shipping Sector Panel: Industry Insights | Mr Edward Buttery - CEO of Grindrod Shipping Holdings Ltd
00:10:00
Solving the Remote Production Puzzle | Carleton Mickey Miller, CEO, Vislink Technologies IncVISL:NAQ
00:10:00
Keith Henderson, President & CEO And Director of Velocity Minerals Ltd., emphasizes the importance of excellent management and provides investors with direct access to vetted companies at the Metals Investor Forum in Vancouver.|Keith Henderson, President
00:10:00
"Interview with John Lai, CEO-President of PetVivo Holdings, Inc."|Mr. Lai has been a director and senior executive officer of PetVivo Holdings.

© 2026 Nehu